Your Location：
Home >
Browse articles >
Targeting Interleukin-6 Pathway in the Treatment of Immune-mediated Inflammatory Diseases： from Bench to Clinic
Invited Review | Updated：2025-12-04
Targeting Interleukin-6 Pathway in the Treatment of Immune-mediated Inflammatory Diseases： from Bench to Clinic
- Journal of Sun Yat-sen University(Medical Sciences) Vol. 46, Issue 5, Pages: 721-729(2025)
DOI： 10.13471/j.cnki.j.sun.yat-sen.univ（med.sci）.2025.0501
Revised：2025-08-13 ，
Accepted：17 August 2025
Scan QR Code
Full Text(HTML)
References
Publication Info
Metrics
996
Views
2868
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Association Analysis Between Gut Microbiota and Prognosis in Patients with Intermediate-to-advanced Hepatocellular Carcinoma Treated with TACE Combined with Targeted Therapy and Immunotherapy
Advances and Novel Therapeutic Strategies in the Immune Microenvironment of Cancer Bone Metastasis
The Role of Complement in MHC Class I Antibody-mediated Transfusion-related Acute Lung Injury
Research Progress on Mitophagy and Energy Metabolism in Digestive Tract Tumors
Research Advances on the Relationship Between Adrenergic Signaling and Neuroblastoma and its Targeted Therapy
Related Author
WU Yanqin
LI Jiaping
FAN Wenzhe
ZHU Bowen
LIU Hang
QU Xia
CHEN Bo
FU Yongshui
Related Institution
Department of Interventional Oncology， The First Affiliated Hospital， Sun Yat-sen University
Department of Orthopedics， The Affiliated Traditional Chinese Medicine Hospital， Southwest Medical University
Guangdong Provincial People's Hospital Affiliated to Southern Medical University
Guangzhou First People's Hospital
Institute of Blood Transfusion， Guangzhou Blood Centre
